This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinkas-Kramarski, R.
Right arrow Articles by Yarden, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinkas-Kramarski, R.
Right arrow Articles by Yarden, Y.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 1998, p. 6090-6101, Vol. 18, No. 10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network

Ronit Pinkas-Kramarski,1 Maya Shelly,1 Bradley C. Guarino,2 Ling Mei Wang,3 Ljuba Lyass,4 Iris Alroy,1 Mauricio Alamandi,3 Angera Kuo,3 James D. Moyer,2 Sara Lavi,1 Miriam Eisenstein,5 Barry J. Ratzkin,6 Rony Seger,7 Sarah S. Bacus,4 Jacalyn H. Pierce,3 Glenn C. Andrews,2 and Yosef Yarden1,*

Departments of Molecular Cell Biology,1 Structural Biology,5 and Membrane Research and Recognition,7 The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 063402; The National Cancer Institute, Bethesda, Maryland 208923; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 601264; and Amgen Center, Thousand Oaks, California 913206

Received 21 August 1997/Returned for modification 21 October 1997/Accepted 7 July 1998

The recently isolated second family of neuregulins, NRG2, shares its primary receptors, ErbB-3 and ErbB-4, and induction of mammary cell differentiation with NRG1 isoforms, suggesting functional redundancy of the two growth factor families. To address this possibility, we analyzed receptor specificity of NRGs by using an engineered cellular system. The activity of isoform-specific but partly overlapping patterns of specificities that collectively activate all eight ligand-stimulatable ErbB dimers was revealed. Specifically, NRG2-beta , like NRG1-alpha , emerges as a narrow-specificity ligand, whereas NRG2-alpha is a pan-ErbB ligand that binds with different affinities to all receptor combinations, including those containing ErbB-1, but excluding homodimers of ErbB-2. The latter protein, however, displayed cooperativity with the direct NRG receptors. Apparently, signaling by all NRGs is funneled through the mitogen-activated protein kinase (MAPK). However, the duration and potency of MAPK activation depend on the identity of the stimulatory ligand-receptor ternary complex. We conclude that the NRG-ErbB network represents a complex and nonredundant machinery developed for fine-tuning of signal transduction.


* Corresponding author. Mailing address: Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel. Phone: 972-8-9342866. Fax: 972-8-9344125. E-mail: liyarden{at}wiccmail.weizmann.ac.il.


Molecular and Cellular Biology, October 1998, p. 6090-6101, Vol. 18, No. 10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Behmoaram, E., Bijian, K., Jie, S., Xu, Y., Darnel, A., Bismar, T. A., Alaoui-Jamali, M. A. (2008). Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB-2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness. Am. J. Pathol. 173: 1540-1550 [Abstract] [Full Text]  
  • Gilbertson, R. J. (2005). ERBB2 in Pediatric Cancer: Innocent Until Proven Guilty. The Oncologist 10: 508-517 [Abstract] [Full Text]  
  • Lu, G., Seta, K. A., Millhorn, D. E. (2005). Novel Role for Cyclin-dependent Kinase 2 in Neuregulin-induced Acetylcholine Receptor {epsilon} Subunit Expression in Differentiated Myotubes. J. Biol. Chem. 280: 21731-21738 [Abstract] [Full Text]  
  • Dobrowsky, R. T., Rouen, S., Yu, C. (2005). Altered Neurotrophism in Diabetic Neuropathy: Spelunking the Caves of Peripheral Nerve. J. Pharmacol. Exp. Ther. 313: 485-491 [Abstract] [Full Text]  
  • Chan, R., Hardy, W. R., Dankort, D., Laing, M. A., Muller, W. J. (2004). Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development. Development 131: 5551-5560 [Abstract] [Full Text]  
  • Bao, J., Wolpowitz, D., Role, L. W., Talmage, D. A. (2003). Back signaling by the Nrg-1 intracellular domain. JCB 161: 1133-1141 [Abstract] [Full Text]  
  • Hendriks, B. S., Opresko, L. K., Wiley, H. S., Lauffenburger, D. (2003). Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor Endocytosis: DISTRIBUTION OF HOMO- AND HETERODIMERS DEPENDS ON RELATIVE HER2 LEVELS. J. Biol. Chem. 278: 23343-23351 [Abstract] [Full Text]  
  • Prevot, V., Rio, C., Cho, G. J., Lomniczi, A., Heger, S., Neville, C. M., Rosenthal, N. A., Ojeda, S. R., Corfas, G. (2003). Normal Female Sexual Development Requires Neuregulin-erbB Receptor Signaling in Hypothalamic Astrocytes. J. Neurosci. 23: 230-239 [Abstract] [Full Text]  
  • Gilbertson, R. J., Bentley, L., Hernan, R., Junttila, T. T., Frank, A. J., Haapasalo, H., Connelly, M., Wetmore, C., Curran, T., Elenius, K., Ellison, D. W. (2002). ERBB Receptor Signaling Promotes Ependymoma Cell Proliferation and Represents a Potential Novel Therapeutic Target for This Disease. Clin. Cancer Res. 8: 3054-3064 [Abstract] [Full Text]  
  • Trivier, E., Ganesan, T. S. (2002). RYK, a Catalytically Inactive Receptor Tyrosine Kinase, Associates with EphB2 and EphB3 but Does Not Interact with AF-6. J. Biol. Chem. 277: 23037-23043 [Abstract] [Full Text]  
  • Chan, R., Hardy, W. R., Laing, M. A., Hardy, S. E., Muller, W. J. (2002). The Catalytic Activity of the ErbB-2 Receptor Tyrosine Kinase Is Essential for Embryonic Development. Mol. Cell. Biol. 22: 1073-1078 [Abstract] [Full Text]  
  • Esparis-Ogando, A., Diaz-Rodriguez, E., Montero, J. C., Yuste, L., Crespo, P., Pandiella, A. (2002). Erk5 Participates in Neuregulin Signal Transduction and Is Constitutively Active in Breast Cancer Cells Overexpressing ErbB2. Mol. Cell. Biol. 22: 270-285 [Abstract] [Full Text]  
  • Bunn, P. A. Jr., Helfrich, B., Soriano, A. F., Franklin, W. A., Varella-Garcia, M., Hirsch, F. R., Baron, A., Zeng, C., Chan, D. C. (2001). Expression of Her-2/neu in Human Lung Cancer Cell Lines by Immunohistochemistry and Fluorescence in Situ Hybridization and its Relationship to in Vitro Cytotoxicity by Trastuzumab and Chemotherapeutic Agents. Clin. Cancer Res. 7: 3239-3250 [Abstract] [Full Text]  
  • Park, S.-K., Miller, R., Krane, I., Vartanian, T. (2001). The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. JCB 154: 1245-1258 [Abstract] [Full Text]  
  • Sartor, C. I., Zhou, H., Kozlowska, E., Guttridge, K., Kawata, E., Caskey, L., Harrelson, J., Hynes, N., Ethier, S., Calvo, B., Earp, H. S. III (2001). HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells. Mol. Cell. Biol. 21: 4265-4275 [Abstract] [Full Text]  
  • Tolcher, A. W. (2001). Novel Compounds in the Therapy of Breast Cancer: Opportunities for Integration with Docetaxel. The Oncologist 6: 40-44 [Abstract] [Full Text]  
  • Ozaki, M. (2001). Neuregulins and the Shaping of Synapses. Neuroscientist 7: 146-154 [Abstract]  
  • Pawson, T., Nash, P. (2000). Protein-protein interactions define specificity in signal transduction. Genes Dev. 14: 1027-1047 [Full Text]  
  • Rosenkranz, S., Ikuno, Y., Leong, F. L., Klinghoffer, R. A., Miyake, S., Band, H., Kazlauskas, A. (2000). Src Family Kinases Negatively Regulate Platelet-derived Growth Factor alpha Receptor-dependent Signaling and Disease Progression. J. Biol. Chem. 275: 9620-9627 [Abstract] [Full Text]  
  • Tagliabue, E., Castiglioni, F., Ghirelli, C., Modugno, M., Asnaghi, L., Somenzi, G., Melani, C., Menard, S. (2000). Nerve Growth Factor Cooperates with p185HER2 in Activating Growth of Human Breast Carcinoma Cells. J. Biol. Chem. 275: 5388-5394 [Abstract] [Full Text]  
  • Spencer, K. S.R., Graus-Porta, D., Leng, J., Hynes, N. E., Klemke, R. L. (2000). ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases. JCB 148: 385-397 [Abstract] [Full Text]  
  • Hertig, C. M., Kubalak, S. W., Wang, Y., Chien, K. R. (1999). Synergistic Roles of Neuregulin-1 and Insulin-like Growth Factor-I in Activation of the Phosphatidylinositol 3-Kinase Pathway and Cardiac Chamber Morphogenesis. J. Biol. Chem. 274: 37362-37369 [Abstract] [Full Text]  
  • Woldeyesus, M. T., Britsch, S., Riethmacher, D., Xu, L., Sonnenberg-Riethmacher, E., Abou-Rebyeh, F., Harvey, R., Caroni, P., Birchmeier, C. (1999). Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development. Genes Dev. 13: 2538-2548 [Abstract] [Full Text]  
  • Adelsman, M. A., McCarthy, J. B., Shimizu, Y. (1999). Stimulation of beta 1-Integrin Function by Epidermal Growth Factor and Heregulin-beta Has Distinct Requirements for erbB2 but a Similar Dependence on Phosphoinositide 3-OH Kinase. Mol. Biol. Cell 10: 2861-2878 [Abstract] [Full Text]  
  • Klapper, L. N., Glathe, S., Vaisman, N., Hynes, N. E., Andrews, G. C., Sela, M., Yarden, Y. (1999). The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc. Natl. Acad. Sci. USA 96: 4995-5000 [Abstract] [Full Text]  
  • Sweeney, C., Fambrough, D., Huard, C., Diamonti, A. J., Lander, E. S., Cantley, L. C., Carraway, K. L. III (2001). Growth Factor-specific Signaling Pathway Stimulation and Gene Expression Mediated by ErbB Receptors. J. Biol. Chem. 276: 22685-22698 [Abstract] [Full Text]